Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tjeffe01
    Junior Member
    • Aug 2013
    • 4

    #1

    Hello

    Hello,

    My name is Taylor. I work at the University of Guelph, in Ontario Canada. I work on glyphosate resistant giant ragweed. We just sent out four samples for RNAseq analysis to look at differences in gene expression between sprayed and unsprayed susceptible and resistant plants.

    Our biggest problem is that we have little to no genetic data available on our species; no reference genome (and only about 40 entries in NCBI).

    Glad to be a part of the community,
    Taylor
  • piyo2
    Junior Member
    • Oct 2010
    • 4

    #2
    If this genome is important, why not go for a de novo assembly to actually have a reference genome? This way you'll have genomic data with RNA-Seq (plus a very nice project and probably a thesis to go with it). I am guessing that ragweed is somewhere between 100-200 Mbp in size. The best de novo assembly strategy is lots of throughput and coverage with Illumina short reads, plus some long PacBio reads to span repeats and join contigs. My best guess is that this will cost $10K (all in at service lab) This doesn't seem out of reach for an important contribution to the field.

    Mike Schatz at CSHL has done a lot of work in this area: http://schatzlab.cshl.edu/presentati...%20Genomes.pdf

    Genome Quebec can provide service and has informatics experience on hybrid de novo assemblies. http://gqinnovationcenter.com/servic...acBio.aspx?l=e

    **Disclaimer: I work for a sequencing company.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...